CYTOSORBENTS CORPORATION Convertible Notes Payable
CYTOSORBENTS CORPORATION (CTSO) had Convertible Notes Payable of $745.00 thousand as of 2014-06-30, per its 10-Q filed 2014-08-12.
Discontinued › Balance Sheet › Liabilities
us-gaap:ConvertibleNotesPayable · last filed 2014-08-12
- 2014-06-30: Convertible Notes Payable $745.00K.
- 2014-03-31: Convertible Notes Payable $1.73M.
- 2013-12-31: Convertible Notes Payable $1.64M.
- 2013-09-30: Convertible Notes Payable $1.56M.
| Period end | Convertible Notes Payable | Convertible Notes Payable as first filed |
|---|---|---|
| 2014-06-30 | $745.00K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $1.73M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $1.64M 10-K · filed 2014-03-31 | |
| 2013-09-30 | $1.56M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $912.11K 10-Q · filed 2013-08-14 | |
| 2012-12-31 | $926.00K 10-K · filed 2014-03-31 | $926.23K 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |